UROKINASE PLASMINOGEN-ACTIVATOR, A STRONG AND INDEPENDENT PROGNOSTIC MARKER IN BREAST-CANCER

被引：0
|
作者：
DUFFY, MJ
REILLY, D
NOLAN, N
OHIGGINS, N
FENNELLY, JJ
ANDREASEN, P
机构：
[1] ST VINCENTS HOSP,DEPT EDUC,DUBLIN 4,IRELAND
[2] ST VINCENTS HOSP,DEPT RES,DUBLIN 4,IRELAND
[3] AARHUS UNIV,INST MOLEC BIOL,DK-8000 AARHUS,DENMARK
来源：
FIBRINOLYSIS | 1992年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Urokinase plasminogen activator (uPA) is a serine protease implicated in cancer invasion and metastasis. In this investigation, we show using both univariate and multivariate analysis that high levels of uPA antigen in primary breast cancer correlates with shortened disease-free interval and shortened overall survival. As a prognostic marker for breast cancer, uPA appears to be stronger than either axillary node status, tumor size, or estrogen receptor (ER) status. In addition, as a prognostic marker, uPA was independent of nodal status, tumor size and ER status. We conclude that uPA is a new and independent prognostic marker in breast cancer.
引用
收藏
页码：55 / 57
页数：3
相关论文
共 50 条
  • [21] COMPARATIVE-STUDY OF 4 EXTRACTION PROCEDURES FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN BREAST-CANCER TISSUES
    ROMAIN, S
    SPYRATOS, F
    LAINEBIDRON, C
    BOUCHET, C
    GUIROU, O
    MARTIN, PM
    OGLOBINE, J
    MAGDELENAT, H
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1995, 33 (09): : 603 - 608
  • [22] Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer
    GrondahlHansen, J
    Peters, HA
    vanPutten, WLJ
    Look, MP
    Pappot, H
    Ronne, E
    Dano, K
    Klijn, JGM
    Brunner, N
    Foekens, JA
    CLINICAL CANCER RESEARCH, 1995, 1 (10) : 1079 - 1087
  • [23] BOTH THE CYTOSOLS AND DETERGENT EXTRACTS OF BREAST-CANCER TISSUES ARE SUITED TO EVALUATE THE PROGNOSTIC IMPACT OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR, PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1
    JANICKE, F
    PACHE, L
    SCHMITT, M
    ULM, K
    THOMSSEN, C
    PRECHTL, A
    GRAEFF, H
    CANCER RESEARCH, 1994, 54 (10) : 2527 - 2530
  • [24] UROKINASE-LIKE PLASMINOGEN-ACTIVATOR AS A MARKER OF ENDOMETRIAL NEOPLASIA
    NIKLASSON, O
    SVANBERG, L
    THORELL, J
    LECANDER, I
    ASTEDT, B
    CANCER, 1981, 48 (06) : 1484 - 1486
  • [25] THE RECEPTOR FOR THE UROKINASE PLASMINOGEN-ACTIVATOR
    BLASI, F
    STOPPELLI, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 236 - 236
  • [26] PROGNOSTIC-SIGNIFICANCE OF IMMUNOHISTOCHEMICAL DETECTION OF UROKINASE PLASMINOGEN-ACTIVATOR IN PRIMARY BREAST CARCINOMAS
    GOHRING, UJ
    SCHARL, A
    THELEN, U
    AHR, A
    TITIUS, BR
    PATHOLOGE, 1995, 16 (06): : 398 - 403
  • [27] PLASMINOGEN-ACTIVATOR INHIBITOR-2 - PROGNOSTIC RELEVANCE IN 1012 PATIENTS WITH PRIMARY BREAST-CANCER
    FOEKENS, JA
    BUESSECKER, F
    PETERS, HA
    KRAINICK, U
    VANPUTTEN, WLJ
    LOOK, MP
    KLIJN, JGM
    KRAMER, MD
    CANCER RESEARCH, 1995, 55 (07) : 1423 - 1427
  • [28] PROGNOSTIC VALUE OF UROKINASE PLASMINOGEN-ACTIVATOR FOR PROSTATIC-CARCINOMA
    LEHMANN, K
    PLAS, E
    GAUTSCHI, K
    HAURI, D
    UROLOGIA INTERNATIONALIS, 1994, 52 (03) : 159 - 161
  • [29] The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
    Ross W. Stephens
    Nils Brünner
    Fritz Jänicke
    Manfred Schmitt
    Breast Cancer Research and Treatment, 1998, 52 : 99 - 111
  • [30] The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
    Stephens, RW
    Brünner, N
    Jänicke, F
    Schmitt, M
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 99 - 111
12345